Innovation
34 patent families (13 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 12,644 times.
| Year | Filings |
|---|---|
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 8 |
| 2021 | 9 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 9 |
| 2026 | 2 |
Social engagement
Social engagement: 6.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 50% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 5 | 42% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
16 Feb 2026 · Controller
Based on job postings tracked across public sources.
Recent activity
28 May 2026
Milestone
revenue
19 May 2026
Product launch
GLIX1 preclinical data
24 Mar 2026
Milestone
revenue